Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 1 EP application Elizabeth Lucy Elmhirst has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 18, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12723216

INACTIVATED DENGUE VIRUS VACCINE

IPC classification:
A61K 39/12, A61K 47/10
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED

Please Sign in to use this feature